Skip to content

Lactobacillus acidophilus DDS-1 and Bifidobacterium lactis UABLa-12 Benefit Patients with Irritable Bowel Syndrome

Written by Angeline A. De Leon, Staff Writer. Supplementation with Lactobacillus acidophilus DDS‐1 (L. acidophilusDDS-1) or Bifidobacterium lactis UABla‐12 (B.lactis UABLa-12), significantly improved symptom severity in participating subjects with Irritable Bowel Syndrome (IBS).

Read more
Back To Top